University of Notre Dame du Lac’s Madrigal Pharmaceuticals MDGL Stock Holding History

University of Notre Dame du Lac’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-12,169	Closed	-$812K	–	51
2020 Q1	$812K	Buy	12,169 +2,491	+26%	+$208K	0.25%	49
2019 Q4	$882K	Sell	9,678 -218	-2%	-$21.1K	0.28%	51
2019 Q3	$853K	Sell	9,896 -24,840	-72%	-$2.33M	0.25%	44
2019 Q2	$3.64M	Buy	34,736 +15,463	+80%	+$1.66M	0.83%	49
2019 Q1	$2.41M	Buy	19,273 +174	+0.9%	+$21.6K	0.54%	57
2018 Q4	$2.15M	Buy	19,099 +7,367	+63%	+$1.14M	0.52%	56
2018 Q3	$2.51M	Buy	+11,732	New	+$2.94M	0.47%	65

Other funds holding MDGL

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

University of Notre Dame du Lac's MDGL Position: Q2 2020 in Review

University of Notre Dame du Lac sold out of Madrigal Pharmaceuticals (MDGL) in Q2 2020, closing a stake of 12,169 shares — an estimated $812K sold.

University of Notre Dame du Lac first reported a position in MDGL in Q3 2018 and held it in 7 quarters. The position peaked at $3.64M in Q2 2019. 125 funds tracked by Wall St. Rank hold MDGL as of Q2 2020.

University of Notre Dame du Lac reported no remaining Madrigal Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
University of Notre Dame du Lac sold 12,169 Madrigal Pharmaceuticals shares in Q2 2020, an estimated $812K.
University of Notre Dame du Lac first reported a position in Madrigal Pharmaceuticals in Q3 2018 and held it in 7 quarters.
University of Notre Dame du Lac's Madrigal Pharmaceuticals position peaked at $3.64M in Q2 2019.
125 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2020.

Based on University of Notre Dame du Lac's 13F filing for Q2 2020, filed 14 Aug 2020.